...
thtx-img

Theratechnologies Inc., Common Stock

THTX

NAQ

$1.66

-$0.11

(-6.21%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$82.25M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
172.53K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.73
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.08 L
$2.58 H
$1.66

About Theratechnologies Inc., Common Stock

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTHTXSectorS&P500
1-Week Return16.9%-3.35%-2.97%
1-Month Return38.33%-3.49%-0.66%
3-Month Return36.07%-12.6%2.71%
6-Month Return31.75%-6.91%7.21%
1-Year Return3.75%1.19%23.04%
3-Year Return-86.83%-0.21%28.43%
5-Year Return-84.91%33.09%82.88%
10-Year Return38.33%93.55%184.63%

Financials

Nov '19Nov '20Nov '21Nov '22Nov '235YR TREND
Total Revenue63.22M66.05M69.82M80.06M81.76M[{"date":"2019-11-30","value":77.32,"profit":true},{"date":"2020-11-30","value":80.78,"profit":true},{"date":"2021-11-30","value":85.4,"profit":true},{"date":"2022-11-30","value":97.91,"profit":true},{"date":"2023-11-30","value":100,"profit":true}]
Cost of Revenue26.08M26.90M23.26M26.28M19.64M[{"date":"2019-11-30","value":96.93,"profit":true},{"date":"2020-11-30","value":100,"profit":true},{"date":"2021-11-30","value":86.46,"profit":true},{"date":"2022-11-30","value":97.68,"profit":true},{"date":"2023-11-30","value":72.99,"profit":true}]
Gross Profit37.14M39.15M46.56M53.78M62.13M[{"date":"2019-11-30","value":59.78,"profit":true},{"date":"2020-11-30","value":63.02,"profit":true},{"date":"2021-11-30","value":74.95,"profit":true},{"date":"2022-11-30","value":86.56,"profit":true},{"date":"2023-11-30","value":100,"profit":true}]
Gross Margin58.75%59.27%66.69%67.17%75.99%[{"date":"2019-11-30","value":77.32,"profit":true},{"date":"2020-11-30","value":78,"profit":true},{"date":"2021-11-30","value":87.76,"profit":true},{"date":"2022-11-30","value":88.4,"profit":true},{"date":"2023-11-30","value":100,"profit":true}]
Operating Expenses45.65M57.11M71.80M93.69M72.76M[{"date":"2019-11-30","value":48.73,"profit":true},{"date":"2020-11-30","value":60.96,"profit":true},{"date":"2021-11-30","value":76.64,"profit":true},{"date":"2022-11-30","value":100,"profit":true},{"date":"2023-11-30","value":77.66,"profit":true}]
Operating Income(8.51M)(17.96M)(25.24M)(39.91M)(10.63M)[{"date":"2019-11-30","value":-851300000,"profit":false},{"date":"2020-11-30","value":-1795700000,"profit":false},{"date":"2021-11-30","value":-2523600000,"profit":false},{"date":"2022-11-30","value":-3990800000,"profit":false},{"date":"2023-11-30","value":-1062700000,"profit":false}]
Total Non-Operating Income/Expense(3.98M)(9.80M)(12.85M)(13.10M)(23.50M)[{"date":"2019-11-30","value":-398300000,"profit":false},{"date":"2020-11-30","value":-979700000,"profit":false},{"date":"2021-11-30","value":-1285200000,"profit":false},{"date":"2022-11-30","value":-1310200000,"profit":false},{"date":"2023-11-30","value":-2349700000,"profit":false}]
Pre-Tax Income(12.50M)(22.65M)(31.66M)(46.79M)(23.54M)[{"date":"2019-11-30","value":-1249600000,"profit":false},{"date":"2020-11-30","value":-2265100000,"profit":false},{"date":"2021-11-30","value":-3166200000,"profit":false},{"date":"2022-11-30","value":-4679400000,"profit":false},{"date":"2023-11-30","value":-2353600000,"profit":false}]
Income Taxes4.99M16.00K63.00K443.00K421.00K[{"date":"2019-11-30","value":100,"profit":true},{"date":"2020-11-30","value":0.32,"profit":true},{"date":"2021-11-30","value":1.26,"profit":true},{"date":"2022-11-30","value":8.88,"profit":true},{"date":"2023-11-30","value":8.44,"profit":true}]
Income After Taxes(17.49M)(22.67M)(31.73M)(47.24M)(23.96M)[{"date":"2019-11-30","value":-1748600000,"profit":false},{"date":"2020-11-30","value":-2266700000,"profit":false},{"date":"2021-11-30","value":-3172500000,"profit":false},{"date":"2022-11-30","value":-4723700000,"profit":false},{"date":"2023-11-30","value":-2395700000,"profit":false}]
Income From Continuous Operations(12.50M)(22.67M)(31.73M)(47.24M)(23.96M)[{"date":"2019-11-30","value":-1249600000,"profit":false},{"date":"2020-11-30","value":-2266700000,"profit":false},{"date":"2021-11-30","value":-3172500000,"profit":false},{"date":"2022-11-30","value":-4723700000,"profit":false},{"date":"2023-11-30","value":-2395700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-11-30","value":"-","profit":true},{"date":"2020-11-30","value":"-","profit":true},{"date":"2021-11-30","value":"-","profit":true},{"date":"2022-11-30","value":"-","profit":true},{"date":"2023-11-30","value":"-","profit":true}]
Net Income(12.50M)(22.67M)(31.73M)(47.24M)(23.96M)[{"date":"2019-11-30","value":-1249600000,"profit":false},{"date":"2020-11-30","value":-2266700000,"profit":false},{"date":"2021-11-30","value":-3172500000,"profit":false},{"date":"2022-11-30","value":-4723700000,"profit":false},{"date":"2023-11-30","value":-2395700000,"profit":false}]
EPS (Diluted)(0.16)(0.29)(0.34)(0.50)(0.66)[{"date":"2019-11-30","value":-16,"profit":false},{"date":"2020-11-30","value":-29,"profit":false},{"date":"2021-11-30","value":-34,"profit":false},{"date":"2022-11-30","value":-50,"profit":false},{"date":"2023-11-30","value":-66,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

THTX
Cash Ratio 0.73
Current Ratio 1.08
Quick Ratio 0.97

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

THTX
ROA (LTM) 11.76%
ROE (LTM) -1116.86%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

THTX
Debt Ratio Lower is generally better. Negative is bad. 1.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.28

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

THTX
Trailing PE NM
Forward PE 19.92
P/S (TTM) 0.98
P/B 20.13
Price/FCF 18
EV/R 1.20
EV/Ebitda 8.75

FAQs

What is Theratechnologies Inc. share price today?

Theratechnologies Inc. (THTX) share price today is $1.66

Can Indians buy Theratechnologies Inc. shares?

Yes, Indians can buy shares of Theratechnologies Inc. (THTX) on Vested. To buy Theratechnologies Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in THTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Theratechnologies Inc. be purchased?

Yes, you can purchase fractional shares of Theratechnologies Inc. (THTX) via the Vested app. You can start investing in Theratechnologies Inc. (THTX) with a minimum investment of $1.

How to invest in Theratechnologies Inc. shares from India?

You can invest in shares of Theratechnologies Inc. (THTX) via Vested in three simple steps:

  • Click on Sign Up or Invest in THTX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Theratechnologies Inc. shares
What is Theratechnologies Inc. 52-week high and low stock price?

The 52-week high price of Theratechnologies Inc. (THTX) is $2.58. The 52-week low price of Theratechnologies Inc. (THTX) is $1.08.

What is Theratechnologies Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Theratechnologies Inc. (THTX) is

What is Theratechnologies Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Theratechnologies Inc. (THTX) is 20.13

What is Theratechnologies Inc. dividend yield?

The dividend yield of Theratechnologies Inc. (THTX) is 0.00%

What is the Market Cap of Theratechnologies Inc.?

The market capitalization of Theratechnologies Inc. (THTX) is $82.25M

What is Theratechnologies Inc.’s stock symbol?

The stock symbol (or ticker) of Theratechnologies Inc. is THTX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top